No association of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in susceptibility to gallbladder cancer

DNA and Cell Biology

Volumn 27, Issue 3, 2008, Pages 127-132

  Srivastava, Anvesha ^a   Pandey, Sachchida N ^a   Pandey, P ^a   Choudhuri, Gourdas ^a   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GALLBLADDER CANCER; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGE FACTORS; AGE OF ONSET; AGED; CARCINOMA; CASE-CONTROL STUDIES; FEMALE; GALLBLADDER NEOPLASMS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEX FACTORS;

EID: 41449091697     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2007.0679     Document Type: Article

References (45)

1. Anderson, C.A.M., Jorgensen, A.L., Deeb, S., McLerran, D., Beresford, S.A.A., and Motulsky, A.G. (2005). Equal proportion of adult male and female homozygous for the 677C/T mutation in the methylenetetrahydrofolate reductase polymorphism. Am J Med Genet 134, 97-99.
2. Bearhs, O., Henson, D., and Hutter, R. (1988). Manual for Staging of Cancer. Lippincott, Philadelphia.
3. Blount, B.C., Mack, M.M., and Wehr, C.M. (1997). Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 94, 3290-3295.
4. Botto, L.D., and Yang, Q. (2000). 5, 10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151, 862-877.
5. Cheradame, S., Fischel, J.L., and Milano, G. (2004). Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity. Br J Cancer 90, 526-534.
6. Chiuve, S.E., Giovannucci, E.L., Hankinson, S.E., Hunter, D.J., Stampfer, M.J., Willett, W.C., and Rimm, E.B. (2005). Alcohol intake and methylenetetrahydrofolate reductase polymorphism modify the relation of folate intake to plasma homocysteine. Am J Clin Nutr 82, 155-162.
7. Choi, S.W., and Mason, J.B. (1998). Folate and colorectal carcinogenesis: is DNA repair the missing link? Am J Gastroenterol 93, 2013-2016.
8. Devi, A.R.R., Govindaiah, V., Ramakrishna, G., and Naushad, S.M. (2004). Prevalence of methylene tetrahydrofolate reductase polymorphism in South Indian population. Curr Sci 86, 440-443.
9. Esteller, M., Garcia, A., Martinez-Palones, J.M., Xercavins, J., and Reventos, J. (1997). Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. Carcinogenesis 18, 2307-2311.
10. Fraumeni, J.F., Jr. (1975). Cancers of the pancreas and biliary tract: epidemiological considerations. Cancer Res 35, 3437-3446.
11. Frosst, P., Blom, H.J., Milos, R., Goyette, P., Sheppard, C.A., Matthews, R.G., Boers, G.J.H., den Heijer, M., Kluijtmans, L.A.J., van den Heuvel, L.P., and Rozen, R. (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10, 111-113.
12. Gershoni-Baruch, R., Dagan, E., Israeli, D., Kasinetz, L., Kadouri, E., and Friedman, E. (2000). Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish women. Eur J Cancer 36, 2313-2316.
13. Giovannucci, C.J., Kelsey, E., Rimm, K., Stampfer, E.B., Colditz, M.J., Spiegelman, G.A., Willett, W.C., and Junter, D.J. (1996). A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 56, 4862-4864.
14. Goodman, M.T., McDuffie, K., and Hernandez, B. (2001). Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia. Cancer Epidemiol Biomarkers Prev 10, 1275-1280.
15. Goyette, P., Pai, A., Milos, R., Frosst, P., Tran, P., Chen, Z., Chan, M., and Rozen, R. (1998). Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mamm Genome 9, 652-656.
16. Goyette, P., Sumner, J.S., Milos, R., Duncan, A.M.V., Rosenblatt, D.S., Matthews, R.G., and Rozen, R. (1994). Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet 7, 195-200.
17. Hagmar, L., Brogger, A., Hansteen, I.L., Heim, S., Hogstedt, B., and Knudsen, L. (1994). Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res 54, 2919-2922.
18. Hekim, N., Ergen, A., Yaylm, H., Ylmaz, H., Zeybek, Ü., and Öztürk, O. (2005). No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer. Cell Biochem Funct 15, 115-117.
19. Houlston, R.S., and Tomlinson, I.P. (2001). Polymorphisms and colorectal tumour risk. Gastroenterology 121, 282-301.
20. Hustad, S., Midttun, Ø., Schneede, J., Vollset, S.E., Grotmol, T., and Ueland, P.M. (2007). The methylenetetrahydrofolate reductase 677C→T polymorphism as a modulator of B vitamin network with major effects on homocysteine metabolism. Am J Hum Genet 80, 846-855.
21. Indian Council of Medical Research (ICMR). (1996). Annual report of population based cancer registries of the National Cancer Registry Programme 1993. ICMR, New Delhi. ICMR Publication, 18.
22. Jiang, Q., Chen, K., Ma, X., Li, Q., Yu, W., Shu, G., and Kaiyan, Y. (2005). Diets, polymorphisms of methylenetetrahydrofolate reductase, and the susceptibility of colon cancer and rectal cancer. Cancer Detect Prev 29, 146-154.
23. Jones, P.A., and Laird, P.W. (1999). Cancer epigenetics comes of age. Nat Genet 21, 163-167.
24. Kimura, F., Florl, A.R., and Steinhoff, C. (2001). Polymorphic methyl group metabolism genes in patients with transitional cell carcinoma of the urinary bladder. Mutat Res 458, 49-54.
25. Kimura, W., Shimada, H., Kuroda, A., and Morioka, Y. (1989). Carcinoma of gallbladder and extra hepatic bile duct in autopsy case of the aged, with special reference to its relationship to gallstone. Am J Gastroenterol 84, 386-390.
26. Krajinovic, M., Lamothe, S., Labuda, D.E., Milie, L.B., Theoret, Y., Moghrabi, A., and Sinnett, D. (2004). Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood 103, 252-257.
27. Lazcano-Ponce, E.C., Miquel, J.F., and Munoz, N. (2001). Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin 51, 349-364.
28. Le Marchand, L., Wilkens, L.R., Kolonel, L.N., and Henderson, B.E. (2005). The MTHFR C677T polymorphism and colorectal cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 14, 1198-1203.
29. Li, C.M., Zhang, C., Lu, X.L., Feng, H.Y., Su, Q.X., and Zeng, Y. (2006). Relationship between methylenetrahydrofolate reductase gene and ischemic stroke. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 18, 264-267.
30. Miao, X., Xing, D., Tan, W., Qi, J., Lu, W., and Lin, D. (2002). Susceptibility to gastric cardia adenocarcinoma and genetic polymorphisms in methylenetetrahydrofolate reductase in an at-risk Chinese population. Cancer Epidemiol Biomarkers Prev 11, 1454-1458.
31. Miller, S.A., Dykes, D.D., and Polesky, H.F. (1988). A salting procedure for extracting DNA from nucleated cells. Nucleic Acids Res 16, 1215.
32. Misra, S., Chaturvedi, A., Misra, N.C., and Sharma, I.D. (2003). Carcinoma of the gallbladder. Lancet Oncol 4, 167-176.
33. Paz, M.F., Avila, S., Fraga, M.F., Pollan, M., Capella, G., Peinado, M.A., Sanchez-Cespedes, M., Herman, J.G., and Esteller, M. (2002). Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res 62, 4519-4524.
34. Rai, A., Mohapatra, S.C., and Shukla, H.S. (2004). A review of association of dietary factors in gallbladder cancer. Ind J Cancer 41, 147-151.
35. Reddy, H., and Jamil, K. (2006). Polymorphisms in the MTHFR gene and their possible association with susceptibility to childhood acute lymphocytic leukemia in an Indian population. Leuk Lymphoma 47, 1203-1204.
36. Ryan, B.M., Molloy, A.M., McManus, R., Arfin, Q., Kelleher, D., Scott, J.M., and Weir, D.G. (2001). The methylenetetrahydrofolate reductase (MTHFR) gene in colorectal cancer: role in tumor development and significance of allelic loss in tumor progression. Int J Gastrointest Cancer 30, 105-112.
37. Shen, H., Spitz, M.R., Wang, L.E., Hong, W.K., and Wei, Q. (2001). Polymorphism of methylenetetrahydrofolate reductase and risk of lung cancer: a case control study. Cancer Epidemiol Biomarkers Prev 10, 397-401.
38. Skibola, C.F., Smith, M., and Kane, E. (1999). Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 96, 12810-12815.
39. Song, C., Xing, D., Tan, W., Wei, Q., and Lin, D. (2001). Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 61, 3272-3275.
40. Toffoli, G., Veronesi, A., Boiocchi, M., and Crivellari, D. (2000). MTHFR gene polymorphism and severe toxicity during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil (CMF). Ann Oncol 11, 373-374.
41. Wang, J., Gajalakshmi, V., Jiang, J., Kuriki, K., Suzuki, S., Nagaya, T., Nakamura, S., Akasaka, S., Ishikawa, H., and Tokudome, S. (2006). Associations between 5, 10 methylene-tetrahydrofolate reductase codon 677 and 1298 genetic polymorphisms and environmental factors with reference to susceptibility to colorectal cancer: a case-control study in an Indian population. Int J Cancer 118, 991-997.
42. Wiemels, J.L., Smith, R.N., Taylor, G.M., Eden, O.B., Alexander, F.E., and Greaves, M.F. (2001). Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci USA 98, 4004-4009.
43. Wistuba, I.I., and Gazdar, A.F. (2004). Gallbladder cancer: lessons from a rare tumor. Nat Rev Cancer 4, 695-706.
44. Yajnik, C.S., Deshpande, S.S., Lubree, H.G., Naik, S.S., Bhat, D.S., Uradey, B.S., Deshpande, J.A., Rege, S.S., Refsum, H., and Yudkin, J.S. (2006). Vitamin B12 deficiency and hyperhomocysteinemia in rural and urban Indians. J Assoc Physicians India 54, 775-782.
45. Zijno, A., Andreoli, C., Leopardi, P., Marcon, F., Rossi, S., Caiola, S., Verdina, A., Galati, R., Cafolla, A., and Crebelli, R. (2003). Folate status, metabolic genotype, and biomarkers of genotoxicity in healthy subjects. Carcinogenesis 24, 1097-1103.